prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |review
And I want to share with you a little bit of the data we’ve gotten from the UPMC insurance plan. The data we have is actually fairly rough because I think we’ve been working with the people down in Chatham Center for probably two or three years to try and get them to release the data to us and it was about two weeks ago that they actually sent it. And now we are trying to clean it up and actually get it in some form that we can use it. But, what I have here and what I’m told I’m allowed to talk about is the commercial data by which that means everybody who isn’t on Medicaid in the Health Plan. The Medicaid data is actually even more interesting – the patterns of use of pharmaceutical agents. For whatever reason they told us we’re not supposed to talk about that yet. About 15% of the total Health Plan members in UPMC had some claim because of LBP during last year. Total cost was $6.5 million. And about somewhat more than half of these people also had pharmacy claims. Generally what the physician will prescribe for LBP are narcotics, NSAID’s, Cox2’s, or some sort of analgesics.